Posts

Showing posts from February, 2022

Awareness and acceptability are fuelling the growth of the Rapid Diagnostic Tests market

Image
  The need for timely diagnosis as a first step in the treatment pathway is creating commendable growth opportunities for rapid tests.     For most people in India, the utility of rapid tests is limited to a pregnancy home test. However, these tests are also deployed as a screening tool for malaria, dengue and critical infections and most recently, COVID-19. In fact, the pandemic has generated widespread awareness for these tests making them a house-hold name. Growth drivers for the Rapid Diagnostic Tests (RDT) market The global RDT market stood at USD 23 bn in 2020 and is expected to grow at a steady CAGR of 8.14% up to 2026*. In India too, RDTs are gaining ground. Several factors are contributing to the growth of the market: Prevalence of infectious diseases including vector-borne diseases: Along with NCDs, India faces challenge from a range of infectious diseases including vector-borne diseases. The good news is that as a country we have made progress to achieve the elimination goal